Clinical Trials in Maryland

Showing 16241-16260 of 23,284 trials

Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea

NCT02067676

The purpose of this study is to assess the safety of increasing doses of a potential vaccine against Campylobacter with and without Alhydrogel®, an aluminum hydroxide adjuvant. This study will also assess immune responses induced by the vaccine.

Campylobacter Infection

U.S. Army Medical Research and Development Command48 participantsStarted Apr 2014

Silver Spring, Maryland, United States

TERMINATEDPhase 117 miles

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

NCT02223598

The purpose of this study is to determine the safety, tolerability, dose limiting toxicities, and maximum tolerated dose of CB-5083 in subjects with lymphoid hematological malignancies.

Lymphoid Hematological MalignanciesRelapsed and Refractory Multiple Myeloma

Cleave Biosciences, Inc.120 participantsStarted Aug 2014

Duarte, California, United States • San Francisco, California, United States • Atlanta, Georgia, United States +5 more locations

COMPLETEDNA17 miles

Prevention of Obesity in Military Communities - Fit4Duty

NCT02679937

This randomized controlled trial assesses the efficacy of a 6-week, dissonance-based, weight-gain prevention program (Fit4Duty) designed to reduce unhealthy weight gain among military service members at-risk for obesity. The Fit4Duty program is an adaptation for the military of an existing civilian obesity prevention program, Project Health, which reduced obesity onset by 50% in healthy civilian young adults. Fit4Duty is compared to a nutrition education control condition and is hypothesized to reduce excess weight gain beyond the control comparison program during the 2 year period following study participation.

ObesityOverweightAdiposity

Henry M. Jackson Foundation for the Advancement of Military Medicine119 participantsStarted Jun 2014

Bethesda, Maryland, United States • Tacoma, Washington, United States

Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

Prevention of Obesity in Military Communities - Fit4Duty

Find Trials by Condition in Maryland

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma

Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis

Understanding the Value of Community Vital Signs in Primary Care

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Telotristat Etiprate for Carcinoid Syndrome Therapy

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis

Third International Study on Mechanical Ventilation

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Dropless vs. Standard Drops Contralateral Eye Study